Myosana Therapeutics Inc.

CIK 1955277 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Myosana Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Apr 28, 2026C/A0001955277-26-000001
Nov 13, 2025C0001955277-25-000002
Dec 7, 2022D0001955277-22-000001